Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ImmunityBio Inc. Common Stock (IBRX) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance

ImmunityBio Inc. Common StockTrade
iShares 0 3 Month Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

ImmunityBio Inc. Common Stock vs iShares 0 3 Month Treasury Bond ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while iShares 0 3 Month Treasury Bond ETF trades at $100.51 (market cap $114.04B). The key difference: iShares 0 3 Month Treasury Bond ETF is far larger — about 11× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares 0 3 Month Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and iShares 0 3 Month Treasury Bond ETF for 50 Days on average.

IBRXSGOV
Market Cap
$10.33B$114.04B
Volume
11,745,19819,563,576
Sector
HealthFixed Income
52-Week High
$11.55$100.72
52-Week Low
$1.98$100.28
Typical Hold Time
0 Days50 Days
Enterprise Value
$10.79B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ImmunityBio Inc. Common Stock

No Aura AI signal available yet.

iShares 0 3 Month Treasury Bond ETF

SGOV (iShares 0-3 Month Treasury Bond ETF) trades at $100.465 with minimal daily movement, reflecting its stable Treasury bill focus. The ETF shows bearish technical signals with 17 sell indicators versus 4 buys, though RSI levels suggest potential oversold conditions. Recent institutional selling by Envestnet Asset Management (-13.2% in Q2 2026) contrasts with consistent dividend distributions around $0.30-0.31 monthly.

SGOV provides stable income exposure to short-term US Treasuries amid rising bond yields, but faces headwinds from the ongoing bond market rout. The ETF's defensive positioning appeals to income-focused investors, though continued yield increases could pressure near-term performance. Current technical weakness suggests cautious entry points may emerge.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBRX
100% Buy0% Sell
Avg holding period · 0 Days
SGOV
59% Buy41% Sell
Avg holding period · 50 Days

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →

About iShares 0 3 Month Treasury Bond ETF

SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.

Read more on SGOV →